Stay updated on Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a Locations section with Texas as a study site and updated the revision to v3.3.3; the old Texas Locations label and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:33:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Site revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:49:34.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Removed the government funding notice warning that information may be out of date and transactions may not be processed due to a lapse in appropriations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:15:49.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The differences are cosmetic UI updates and an updated last updated date, with core trial information unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:22:58.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    - The page now reflects a shift from “Active, not recruiting” and various past dates to a more definitive status with newer dates and the label “Actual.” The timeline references have been updated to 2025 dates, and the update labeling changes to include “Last Update Posted (Estimated)” followed by a 2025-10- date.
    Difference
    2%
    Check dated 2025-10-20T14:22:46.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a path to updates, plus a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T06:57:46.000Z thumbnail image

Stay in the know with updates to Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.